Between 2021 and 2024, global medication shortages have become increasingly severe, affecting numerous commonly used drugs and medical supplies in both developed and developing countries.

Multiple factors have contributed to these shortages, including supply chain disruptions, demand surges linked to pandemics and disease outbreaks, manufacturing delays, and quality control shutdowns.

In the United States, early 2024 data indicated a record high shortage of 323 medications, surpassing previous peaks.

These shortages span various drug categories, including critical cancer chemotherapy drugs, widely used diabetes medications (such as Ozempic and Mounjaro), allergy treatments like adrenaline, and common antibiotics such as amoxicillin used in pediatric care.

The ADHD medication Adderall has also been persistently scarce since late 2022.

Key causes are a fragmented drug supply chain heavily reliant on overseas production in countries like India and China, manufacturing and quality problems (including factory closures following regulatory inspections), and unexpected demand spikes notably for weight-loss drugs during the COVID-19 pandemic.

The American Society of Health System Pharmacists (ASHP) and health policy experts have flagged the ongoing crisis, emphasizing that resolving the shortages will require structural reforms, better manufacturer transparency, regulatory oversight improvements, and heightened investment in domestic manufacturing capacity.

The U.S. government has proposed multi-billion-dollar funding initiatives and expanded FDA authority to address these issues [5ce83679-158d-4b58-b20f-9f406ab7e58b_193716476, 039b72ee-9139-416e-9f1b-92b866fc03b0_1066817968, ebc2ec54-acc8-403b-b471-ce23708ec58f_626880785].

A notable example involves penicillin G benzathine, the essential treatment for syphilis, which faced acute shortages starting April 2023 due to increased syphilis and strep throat cases and limited production by Pfizer—the sole U.S. manufacturer.

Hospitals were forced to ration supplies, prioritizing pregnant women and newborns to prevent congenital syphilis, while alternative treatments like doxycycline, less effective and more burdensome, were recommended for other patients.

This shortage prompted federal task force mobilization and consideration of a public health emergency declaration, underscoring how shortages led to rationing and compromised patient care .

In Estonia, pharmacies and hospitals faced drug supply difficulties due to both increased demand and active ingredient shortages linked to production problems abroad.

Parents encountered shortages of childhood antibiotics and antipyretics; for renal patients, medicines had to be issued from state reserves.

Healthcare workers grappled with limited information on substitutes, complicating clinical decision-making.

The national Health Insurance Fund relaxed reimbursement rules allowing discounts on alternative medicines to alleviate patient costs.

Authorities emphasized better supply monitoring and proactive solutions to prevent panic and ensure patients did not hoard medications during shortages .

Across health systems, responses included emergency importation efforts, ramping up production (e.g., Pfizer's night and weekend shifts for penicillin), stockpiling, and changes in prescribing guidelines prioritizing scarce drugs for high-risk patients.

Regulatory agencies like the FDA issued draft guidance to require manufacturers to notify them at least six months in advance of potential production halts to allow contingency planning.

Some countries have pursued centralized allocation, enhanced information sharing via digital platforms, and price adjustments to encourage domestic manufacturing and prevent market monopolies.

Taiwan's Ministry of Health and Welfare, for instance, implemented short-, medium-, and long-term strategies involving coordinated interdepartmental responses, improved supply data transparency, and revised pricing policies to stabilize supply

[25a56293-2f73-4173-bc6e-c760e5d9ea19_221025291, 2e719d0e-c92e-4377-9893-e188e27e14f1_328773633, 5ce83679-158d-4b58-b20f-9f406ab7e58b_193716476].

In summary, ordinary patients worldwide have faced medication rationing, therapy delays, and regimen changes that potentially worsen health outcomes.

Healthcare providers are challenged with finding substitute treatments often lacking robust clinical evidence or convenience.

Authorities have responded with multi-faceted policy and operational measures, yet experts agree fundamental supply chain restructuring and increased transparency are essential to sustainably resolve the global medication shortage crisis.

Data for other developing regions is limited in the current findings; further investigation into low- and middle-income countries' scenarios and responses is recommended for a comprehensive understanding.

Between 2021 and 2024, global medication shortages have become increasingly severe, affecting numerous commonly used drugs and medical supplies in both developed and developing countries.

Title:

Content: Meitu
The first quarter of the United States serious drug shortage 323 drugs urgent cancer patients also have to be diverted and rationed!
CHU HENG NETWORK NEWS CENTER 2024-04-16 10: 42
According to the latest data from the American Society of Health System Pharmacists (ASHP) and the Utah Center for Drug Information Services, a total of 323 drugs in the United States were in severe shortages in the first quarter of this year, surpassing the record of 320 in 2014.
Among the drugs affected are the widely used diabetes drugs Ozempic and Mounjaro, the allergy treatment drug adrenaline, the common antibiotic amoxicillin for children, chemotherapy drugs and injections commonly used in hospitals in intensive care.
ASHP CEO Paul Abramowitz said in a statement that almost all categories of drugs are facing shortages, with non-patented sterile injectable drugs, including cancer chemotherapy drugs, and emergency drugs stored in hospital emergency vans and operating areas, the shortage of such drugs is the most worrying.
According to the American Cancer Society, chemotherapy is one of the top five drugs most affected by the shortage, which threatens to have a devastating impact on patients, and some hospitals and clinics say doctors have had to divert patients to ration their medications because of a shortage of some chemotherapy drugs.
In addition, ASHP noted that the continued nationwide shortage of ADHD drugs is “a problem for clinicians and patients. ”
The shortage of popular drugs is even more acute, with Mounjaro, the diabetes drug known as the “slimming pill ”, already in dire straits.
In response, Lilly said that the “unprecedented surge in demand ” for Mounjaro and its similar drug Zepbound has led to a shortage in the market, which the company is struggling to cope with.
Lilly is ramping up investments to boost production at Mounjaro and Zepbound in the second half of 2024.
The company said it expects intermittent supply disruptions in the near term due to unprecedented demand.
How to cure the drug shortage
The last major “drug shortage ” in U.S. history occurred in 2014, and it has only been alleviated in the years since.
Since 2021, the drug shortage situation seems to be increasing, and scholars in the field of medical health and economics in the United States believe that the reason for most drug shortages in the United States is the fragmentation of the drug supply chain.
The White House this month proposed spending between $3.26 billion and $5.11 billion over the next decade to help address the nation ’ s drug shortage.
The bill requires approval and funding from the U.S. Congress.
U.S. researchers and policymakers believe that a complete solution to the “drug shortage ” may require changes to the business model of the U.S. pharmaceutical industry, including measures to increase the price of generic drugs to attract more drug manufacturers.
Policymakers recommend giving the FDA more power to access more information about drug shortages and impending shortages.
Currently, the FDA relies primarily on phone calls to manufacturers asking if they can increase their supply to understand the situation.
The American Society of Health System Pharmacists said it is working with the federal government to advise the government on measures to address the drug shortage, including that Congress should require manufacturers to be more transparent on any supply chain issues and encourage more diversity in supply chains.
According to Abramowitz, “The federal government still has a lot of work to do to fundamentally address drug shortages, and the American Society of Health System Pharmacists will continue to engage regularly with policymakers to guide them in drafting and passing new legislation to address drug shortages and continue to advocate vigorously for proven solutions on behalf of our members. ”

Multiple factors have contributed to these shortages, including supply chain disruptions, demand surges linked to pandemics and disease outbreaks, manufacturing delays, and quality control shutdowns.

Title:

Content: General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
An Unexpected Catastrophe in the World ’ s Largest Country: The Complete Story of U.S. Drug Shortages
The deficit is at a record level.
According to data from the American Society of Health System Pharmacists and the University of Utah Drug Information Service, organizations began tracking drug shortages for the first time in 2001. Steady since 2021 – now reaching a record high of 323 drugs in the first three months of 2024.
Paul Abramowitz, CEO of the American Society of Health System Pharmacists, wrote in a blog post on Thursday: “It ’ s been a long time to end drug shortages, ” and wrote:“ All drug classes are vulnerable to shortages, some of the most worrisome shortages include sterile injectable generic drugs, including cancer chemotherapy drugs and emergency drugs stored in hospital vans and procedural areas. It is dangerous for doctors and patients. ”
In addition to the 32 chemotherapy drugs that are deficient, the five categories of drugs with the greatest deficiency include central nervous system stimulants, antimicrobials, hormonal agents, and intravenous fluids. [1] The Drug Deficiency Database maintained by the American Society of Health System Pharmacists and the University of Utah is based on voluntary reports from practitioners, patients, and others that have been confirmed by manufacturers. The U.S. drug is in short supply, because it captures broader effects on service providers and patients.
The crisis has lasted a year and a half.
More than half of the treatment shortages have lasted for more than two years, according to an analysis by health consultancy IQVIA, and the average shortage affects at least half a million patients, many of them elderly, according to the US Office of Health and Human Services under the Assistant Secretary for Planning and Evaluation, which shared its analysis with Congress in May.
Growing demand can play a role in drug shortages, as with the recent shortage of weight-loss drugs, but often manufacturing and quality problems, such as supply chain gaps and downtime, are the root cause. And varied.
But the American Society of Health System Pharmacists has “serious concerns ” about parts of this proposal, especially financial sanctions imposed on hospitals that lack the resources to comply with the recommendations, Abramowitz wrote:“ We all know that managing shortages is not enough and is not a sustainable solution to the worsening crisis, and there is still a lot of work to be done at the federal level to fix the root causes of drug shortages. ”
Why Shortage Occurs
Shortages can be caused by high demand, as with the recent shortage of weight-loss drugs, but this is not usually the main problem.
The FDA also blames manufacturing and quality problems, supply chain gaps, and downtime, and Dr. Emily Tucker, a drug shortage expert and an assistant professor of industrial engineering at Clemson University, says that when there is an indication of shortages, large health systems often also proactively place large orders, adding to the system ’ s stress.
“I don ’ t blame anyone.
“When I talk to all the stakeholders – whether it ’ s wholesalers, manufacturers, or the government – everyone wants this problem to end, ” she said.
Lack of transparency
Dr. Julie Grallo, chief medical officer and executive vice president of the American Society of Clinical Oncology, told the House Committee earlier that the shortage puts providers in a terrible position: “The drug shortage crisis is forcing providers to make impossible choices, and it is also hindering the development of new drugs. Health drugs are purchased only on a price basis, and manufacturers do not have to disclose the source of their acquisition of the ingredients.
The shortage of this generic chemical drug came due to the closure of one factory in India that manufactures the active ingredient after a surprise FDA inspection found “significant quality issues, ” says Jarallo:“ We didn ’ t know, and there was no transparency regarding the company ’ s supply of the majority of active pharmaceutical ingredients to all manufacturers across the board.
Knowing this in advance, we could have responded much faster, ” Dr. Steven Schundlemeyer, director of the PRIME Institute of the University of Minnesota School of Pharmacy, which focuses on economic and management issues, told the committee that as with defense contractors in the United States, New Zealand requires manufacturers to disclose their suppliers, and that information is required.
Easily accessible in the database.
Related Topics

In the United States, early 2024 data indicated a record high shortage of 323 medications, surpassing previous peaks.

These shortages span various drug categories, including critical cancer chemotherapy drugs, widely used diabetes medications (such as Ozempic and Mounjaro), allergy treatments like adrenaline, and common antibiotics such as amoxicillin used in pediatric care.

Title:

Content: Today's Paper News Sports Features Business Opinion LEARNS Guide Newsletters Obits Games Archive Notices Core Values
ADVERTISEMENT
ADVERTISEMENT

Rise in syphilis, lack of penicillin worry officials

by Mark Dooley | Today at 4:00 a.m.

A shortage of penicillin to treat a skyrocketing number of syphilis cases is so dire that U.S. health officials are debating the need to declare a public health emergency, according to people familiar with the matter.

Major U.S. medical centers are rationing the recommended treatment for the deadly sexually transmitted disease because of a supply crunch. From Michigan to Missouri to Texas, some health care providers are prioritizing giving a key treatment -- penicillin G benzathine -- to pregnant patients and babies, because the drug can pass through the placenta and also treat the fetus.

Syphilis has been sickening more people over the past few years, but the latest surge in cases has been especially worrying to the federal government. The Department of Health and Human Services is mobilizing a new federal task force to tackle the problem, and staff members are discussing the possibility of declaring a public health emergency, which could give officials access to more funding to address the crisis, according to people familiar with the matter.

"This is a remarkable shortage," said Joseph Cherabie, an assistant professor at Washington University in St. Louis' medical school, who treats syphilis patients. Because of the need to conserve the drug for pregnant patients, other people are getting less-than-ideal treatments for the infection.

The government's efforts are being led by Assistant Secretary for Health Adm. Rachel Levine, according to one of the people, who asked not to be identified discussing private information. Levine has spent months recruiting experts to tackle the syphilis crisis, including officials at HHS, the Centers for Disease Control and Prevention and the Food and Drug Administration, which has been brought in to address ongoing drug shortages.

Levine and U.S. health officials at the CDC are weighing the benefits of the public health emergency declaration, such as the additional flexibility and money it would give HHS, one of the people said. They're also considering the potential drawbacks. Some are wary that a pandemic-fatigued public may consider it an overreaction and ignore similar declarations in the future. Ultimately, HHS Secretary Xavier Becerra has the power to make a declaration.

"The department is closely monitoring the alarming rise in cases of syphilis and will continue working to address this public health threat," an HHS spokesperson said.

Drug shortages, though not uncommon, have hit nine-year highs in the U.S. Over the past year there have been shortages of antibiotics, chemotherapies and ADHD medicines, to name a few.

The situation is partly a result of under-investment in manufacturing after years of falling generic drug prices. Companies have also been caught off-guard by unexpected changes in demand, creating far-reaching consequences that imperil lives.

The penicillin shortage began in April. The FDA said it was caused by increases in cases of syphilis and strep throat. Because a common antibiotic used to treat strep was in short supply this winter, patients were prescribed penicillin as an alternative, driving up demand for the drug.

That created an acute problem at a time when syphilis cases were rising precipitously. Rates of syphilis in 2021 were the highest since 1990, according to the most updated government data. In 2021, at least 176,000 cases of syphilis were reported, 32% more than the year before. The infection disproportionately impacts gay and bisexual men.

Pfizer Inc. is the only company that makes penicillin G benzathine for the U.S., selling it under the brand name Bicillin L-A.

The company has told the FDA that supply disruptions for the two most common doses of penicillin G benzathine will likely continue into the second quarter of 2024. Pfizer has added night and weekend shifts to increase production. To free up manufacturing resources, it's also deprioritized production of a smaller dose of Bicillin L-A that's not widely used.

Syphilis is especially dangerous for pregnant people, who can pass it on to a fetus, which often results in pregnancy loss, death of a baby shortly after birth or severe disability in children. Cases of this type of syphilis, called congenital syphilis, are also at their highest rates since the 1990s. In 2021, there were 2,855 cases reported, up 32% from the year prior. The disease is completely preventable with penicillin G benzathine.

Penicillin G benzathine is also often the most recommended treatment for people who aren't pregnant. Yet with supplies running short, the CDC is advising that doctors turn to another antibiotic, doxycycline. That's less convenient for patients, because doxycycline is a pill given twice a day for at least two weeks, whereas penicillin G benzathine is an injection that can sometimes clear the disease completely with one dose.

That makes doctors worry that some patients might not complete their treatment with doxycycline. Syphilis particularly affects people suffering from substance abuse, housing instability or homelessness, which makes it more difficult to sustain long-term medical care.

There's also less evidence backing the drug than there is for penicillin, according to physicians.

"We're learning in real time how effective doxycycline can be," Cherabie said.

Some states or health systems are directing doctors to use doxycycline for syphilis. The Michigan Department of Health and Human Services has instructed state-funded clinics to use doxycycline for certain patients because of the shortage, spokesperson Chelsea Wuth said.

At Houston Methodist, a health system with seven hospitals in the Houston area, penicillin G benzathine is reserved for pregnant patients and babies with syphilis, spokesperson Gale Smith said.

Some clinics have been able to get sufficient amounts of the Pfizer drug, at least for the time being. State-operated health clinics in South Carolina have been able to purchase as much as they need, a spokesperson for the health and environment department said.

While rates of HIV have been declining, other sexually transmitted diseases have become more prevalent in recent years. Condom use has fallen as more effective medications for HIV have become available, leaving people vulnerable to illnesses like syphilis, chlamydia and gonorrhea.

There are also fewer resources to identify people who need treatment and get them help. STD prevention work happens largely at local and state public-health departments, which have been losing money and staff over the years. The covid-19 pandemic diverted already scarce public health resources away from STD work.

The rise in syphilis cases is also prompting concern at a state level. Last year, New Mexico renewed a statewide public health order mandating that health care providers screen pregnant women for syphilis multiple times to catch the disease. The state had only one case of congenital syphilis reported in 2017. It had 42 in 2020.

Print Headline: Rise in syphilis, lack of penicillin worry officials

ADVERTISEMENT

Sponsor Content

ADVERTISEMENT
ADVERTISEMENT

The ADHD medication Adderall has also been persistently scarce since late 2022.

Title:

Content: My channel
* Drag categories can be customized sorting
Recover Default OK
Setup
Alert
Murdered roommate, mutilated body hidden in apartment freezer, New York terror couple arrested
Inflation and Geopolitical Dow Drops 475 Points
The shortage of 323 medical drugs is the worst since 2001.
According to the American Society of Health-System Pharmacis (ASHP), 323 medical drugs are currently in short supply, breaking the previous record of 320 shortages in 2014 and the most severe since tracking drug shortages began in 2001.
ASHP ’ s collaborative survey with the Utah Drug Information Service found that drug shortages in the United States are increasing and show no signs of improvement.
The institute said that all kinds of drugs are at risk of being out of stock, and the most worrying is the lack of even general injection disinfection drugs, including cancer chemotherapy drugs, and emergency medicine stores in hospitals and surgery departments.
Adderall, which is used to treat ADHD and narcolepsy, is one of the most difficult drugs to track and has been in short supply since October 2022. The Drug Enforcement Administration said last fall that more than a dozen pharmaceutical companies said they intended to increase adderall production, but ASHP noted that the problem persists to this day.
Members of the Society of Pharmacists say there is a national shortage of drugs to treat ADHD, which is still causing problems for medical personnel and patients.
Adderall will be short of loans, one of the reasons is that during the Covid-19 period, the use of large, delayed production by major manufacturers, and other manufacturers can not meet production targets.
In its quarterly report, ASHP noted that most pharmaceutical companies are reluctant to disclose the cause of the drug supply shortage.
Experts believe that the rapid increase in demand, supply is too late, pharmaceutical companies are limited, and the supply chain of pharmaceutical materials is blocked.
Cancer Epidemic Health Insurance
The last one.
Watch out for mentally retarded wife, talk show host Jay Leno gets custody
The next one.
One dead, 13 injured, 18 trucks deliberately rammed the office building of the Texas Department of Public Security.
Extended reading
Super-popular
More >

Key causes are a fragmented drug supply chain heavily reliant on overseas production in countries like India and China, manufacturing and quality problems (including factory closures following regulatory inspections), and unexpected demand spikes notably for weight-loss drugs during the COVID-19 pandemic.

The American Society of Health System Pharmacists (ASHP) and health policy experts have flagged the ongoing crisis, emphasizing that resolving the shortages will require structural reforms, better manufacturer transparency, regulatory oversight improvements, and heightened investment in domestic manufacturing capacity.

The U.S. government has proposed multi-billion-dollar funding initiatives and expanded FDA authority to address these issues [5ce83679-158d-4b58-b20f-9f406ab7e58b_193716476, 039b72ee-9139-416e-9f1b-92b866fc03b0_1066817968, ebc2ec54-acc8-403b-b471-ce23708ec58f_626880785].

A notable example involves penicillin G benzathine, the essential treatment for syphilis, which faced acute shortages starting April 2023 due to increased syphilis and strep throat cases and limited production by Pfizer—the sole U.S. manufacturer.

Hospitals were forced to ration supplies, prioritizing pregnant women and newborns to prevent congenital syphilis, while alternative treatments like doxycycline, less effective and more burdensome, were recommended for other patients.

This shortage prompted federal task force mobilization and consideration of a public health emergency declaration, underscoring how shortages led to rationing and compromised patient care .

In Estonia, pharmacies and hospitals faced drug supply difficulties due to both increased demand and active ingredient shortages linked to production problems abroad.

Title:

Content: Drug supply problems have worsened in Estonia
This year, pharmacies in Estonia faced a much larger shortage of drugs than a year earlier.
Problems with supplies are caused by both increased demand and shortage of raw materials, reports rus.err with reference to "Actual chamber".
This spring, parents faced a shortage of antibiotics and antipyretic drugs suitable for children, and in the fall, the Sorbister drug for renal patients had to be issued from the state reserve stock, since it was not enough due to supply problems in pharmacies.
Hospitals are also facing a severe shortage of medicines this year.
“For example, hospitals use very important drugs to treat the consequences of heart attacks and strokes, the supply problems of which have been observed for a year, but thanks to good cooperation, we were able to ensure that no one was left without treatment, ” said Marco Tiisler, head of the Import and Export Supervision Department of the Drug Department.
In 2021, there was a shortage of 183 drugs in pharmacies, last year - 359, as of the end of this year - 450 drugs, and in the case of 130 drugs, the cause of the deficiency is unknown.
The second significant reason was a sudden surge in demand, for example, for the drug Ozempic, which is popular among those who lose weight, but drugs can be in short supply due to problems with production.
- Producers lack the active ingredient.
The active substances come from third countries, they are not always available, this was stated by one of the largest European manufacturers of antibiotics, - said Tiisler.
Drug supply problems put not only patients in a difficult position, but also doctors who have to quickly find replacements, sometimes in conditions of scarce information about alternatives.
If earlier, in the case of a shortage of drugs, the patient had to pay the full cost of the drug prescribed as a substitute, recently the Health Insurance Fund, as an exception, decided to extend the discount to some alternatives.
According to Lee Rootslane, head of the Union of Pharmacies, problems with the supply of medicines are a growing problem throughout Europe.
- This year, in cooperation with the Drug Department and family doctors, we made recommendations so that if a problem arises, we do not solve it after the fact, but try to provide some solutions and avoid panic.
In the case of children ’ s syrups, people read about the shortage of syrup, went to the pharmacy and took two syrups instead of the usual one, ” Rootslane said.
The drug department recommends having a weekly supply of non-prescription drugs and a monthly supply of prescription drugs at home.
Comments
Back to top

Parents encountered shortages of childhood antibiotics and antipyretics; for renal patients, medicines had to be issued from state reserves.

Healthcare workers grappled with limited information on substitutes, complicating clinical decision-making.

The national Health Insurance Fund relaxed reimbursement rules allowing discounts on alternative medicines to alleviate patient costs.

Authorities emphasized better supply monitoring and proactive solutions to prevent panic and ensure patients did not hoard medications during shortages .

Title:

Content: The lack of medicine continues to burn!
The Ministry of Health and Welfare has proposed a short, medium and long-term strategy to deal with the current 5 coping mechanisms.
Journalist Yen Zhenzhen / Taipei Report
According to the Ministry of Health and Welfare, the shortage of drugs is not a single factor, but includes supply problems, manufacturing problems, clinical demand factors, uneven distribution of drugs, drug use habits and drug prices. In addition to dealing with the relatively high clinical demand items, it is properly allocated to all levels of medical institutions and pharmacies to fully meet the needs of clinical end-use drugs.
This is an advertisement, please continue reading.
In the face of the shortage of drugs, Wang said, the existing health insurance uses five major coping mechanisms, including 1, a single processing window, a dedicated person to help deal with the problem of drug purchase, and contact the Food and Drug Administration to put relevant information on the website of the NHI. (4) Drug price adjustment mechanism that does not meet the cost can be re-checked according to the way of raising the price of special drugs; (5) Alternative drugs can still declare the cost, if they are not irreplaceable, they can be replaced at the same price or lower than the original prescription drug price.
In addition, Wang pointed out that in the face of the international epidemic, the Russian-Ukrainian war, and labor shortage, drug shortage is a problem facing all countries. In order to strengthen the stable supply mechanism of drugs in China, the Ministry of Health and Welfare continues to actively respond to the short-term strategy to solve the problem of drug shortage. The Food and Drug Administration (FDA) and the pharmaceutical industry have made every effort to actively arrange production lines, strive for early import, increase production / import quantity, and properly distribute to all levels of medical institutions and pharmacies to fully meet the demand for clinical end use drugs.
In addition, to properly handle the issue of drug price adjustment, the Central Health Insurance Administration of the Ministry of Health and Welfare intends to implement the "Universal Health Insurance Cost Distribution Target System (DET)" in April this year, which will adjust the number of drug prices and adjust the quota in a suitable manner, taking into account factors such as the epidemic, the Russian-Ukrainian war and inflation.
In terms of medium-term strategy, Wang said that he will establish a permanent drug shortage treatment center and optimize drug supply information transmission.
In order to speed up the handling of drug shortage incidents, we will adopt dedicated personnel and cross-departmental cooperation to develop drug shortage prevention policies to prevent drug shortage in advance, strengthen cross-departmental data integration and proactive monitoring to detect drug shortage incidents at an early stage, and intervene early through cross-departmental cooperation to stabilize drug supply.
At the same time, the Food and Drug Administration (FDA) continues to disseminate drug supply and alternative drug information through various channels. In addition to posting on the “Drug Supply Information Platform ”, the FDA will notify medical institutions and pharmacies through VPN, and weekly letters to relevant medical associations and public associations to inform members. Management system.
In the long-term strategy section, it includes reviewing the current health insurance drug pricing policy and encouraging the production of domestically manufactured generic drugs.
Wang Bi-sheng pointed out that in the review of the current health insurance drug price policy, including the development of the price protection of indicative drugs, drug price review for the lack of drugs; start the review of drug expenditure target (DET), plan the establishment of a risk control mechanism, plan the national unified procurement trial plan; comprehensively review the health insurance drug price policy, give an appropriate price protection mechanism for necessary drugs, and also target the patent period. To encourage the production of domestic manufacturers to ensure that when there is a shortage of original pharmaceutical products, there are domestic famous drugs to respond.
Wang also stressed that the Food and Drug Administration has set up a "Drug Supply Information Platform" (https: / / dsms.fda.gov.tw /), reporting hotline (02) 27878249. If medical institutions and pharmacies have any shortage of drugs, they can go to the platform for enquiry or notification, and the department will deal with it immediately.
This is an advertisement, please continue reading.

Across health systems, responses included emergency importation efforts, ramping up production (e.g., Pfizer's night and weekend shifts for penicillin), stockpiling, and changes in prescribing guidelines prioritizing scarce drugs for high-risk patients.

Regulatory agencies like the FDA issued draft guidance to require manufacturers to notify them at least six months in advance of potential production halts to allow contingency planning.

Title:

Content: FDA gave instructions to pharmaceutical manufacturers to prevent the risk of defects
The FDA has released a draft guideline that will allow pharmaceutical manufacturers to more accurately report disruptions to the production of drugs and APIs.
In particular, it specifies who should contact the regulator in case of a failure in production and on which products it is necessary to transmit information.
The U.S. Food and Drug Administration (FDA) has issued draft guidelines to pharmaceutical manufacturers to prevent the risk of flaw.
According to the instructions, they will notify the agency of changes in the manufacturing process of drugs, biological products or active pharmaceutical ingredients (API).
In the United States, FD & C. It requires manufacturers to notify the agency of interruptions in the supply of products or APIs.
The FDA ’ s new guidelines provide clarifications.
Manufacturers must submit a notice to the FDA at least six months before stopping drug production, which could lead to their shortages on the market.
If it is not possible to notify the agency six months in advance, it should be done “as soon as possible ”.
If interruptions in production may affect the supply situation, the manufacturer should assess the situation only on the basis of its capabilities.
It should not take into account the capacity of other manufacturers, the amount of product on the market or market demand.
The guidelines also state what specific product or API information manufacturers should report when informing the FDA.
CBS, citing a report from the US Senate, writes that by the end of 2022, the shortage of drugs in the US had reached a five-year peak and affected almost 300 pharmaceutical products.
This is due to the fact that the United States moved production to China, India and other countries.
According to the American Society of Health System Pharmacists, products such as sodium chloride solution, the antibiotic amoxicillin and albuterol inhalation solution are now in short supply.
Nikolay Sokolov
pharmvestnik

Some countries have pursued centralized allocation, enhanced information sharing via digital platforms, and price adjustments to encourage domestic manufacturing and prevent market monopolies.

Taiwan's Ministry of Health and Welfare, for instance, implemented short-, medium-, and long-term strategies involving coordinated interdepartmental responses, improved supply data transparency, and revised pricing policies to stabilize supply

[25a56293-2f73-4173-bc6e-c760e5d9ea19_221025291, 2e719d0e-c92e-4377-9893-e188e27e14f1_328773633, 5ce83679-158d-4b58-b20f-9f406ab7e58b_193716476].

In summary, ordinary patients worldwide have faced medication rationing, therapy delays, and regimen changes that potentially worsen health outcomes.

Healthcare providers are challenged with finding substitute treatments often lacking robust clinical evidence or convenience.

Authorities have responded with multi-faceted policy and operational measures, yet experts agree fundamental supply chain restructuring and increased transparency are essential to sustainably resolve the global medication shortage crisis.

Data for other developing regions is limited in the current findings; further investigation into low- and middle-income countries' scenarios and responses is recommended for a comprehensive understanding.

Title:

Content: Skip to main content
Publish date:

Compounding Pharmacies Market To Grow US$ 14,116.4 Mn By End Of 2028, Says Coherent Market Insights

SEATTLE, Nov. 8, 2021 /PRNewswire/ -- According to Coherent Market Insights, The global compounding pharmacies market is estimated to account for 14,116.

SEATTLE, Nov. 8, 2021 /PRNewswire/ -- According to Coherent Market Insights, The global compounding pharmacies market is estimated to account for 14,116.4 Mn in terms of value by the end of 2028.

In the field of medicine, compounding pharmacies are places where different compounds are made to remedy a disease or condition. These pharmacies have the ability to create customized formulas in accordance with the requirements of the patients. Compounding pharmacies usually employ the most modern and safe compound preparation techniques, as well as the most up-to-date equipment and facilities. They also have access to some of the best quality products in the market. In the world of pharmaceuticals, compounding pharmacies play an important role. Their main job is to design a unique formulation for a medicine that is unable to be manufactured under the conditions dictated by the manufacturer.

Ask for Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/3199

Market Drivers

1.  Increasing geriatric population and growing acceptance of personalized medicines is expected to  drive growth of the global compounding pharmacies market during the forecast period

According to the World Health Organization (WHO), by 2050, the global population aged 65 years and above is expected to reach around 2 billion increasing from 900 million in 2015. Since elderly people are most susceptible to various chronic diseases such as cardiovascular disease, the demand for personalized medicines has increased significantly over the years. Compounding pharmacies are a method of creating customized medications according to a patient's specific requirements.

2.  Rising research and development activities pertaining to topical formulations is expected to propel the global compounding pharmacies market growth over the forecast period

The demand for topical formulations such as gels, creams, ointments, and other similar products. Topical medications are applied to the skin or mucous membranes that allow it to enter the body. Key companies in the pharmaceutical industry are focused on research and development activities, in order to innovate novel topical formulations. Thus, such factors are expected to propel the market growth in the near future.

Market Opportunities

1.  Increasing demand for unavailable drugs can present lucrative growth opportunities in the market

Unavailable drugs refer to back-ordered medicines due to manufacturing problems or discontinued drugs due to decreased usage or declining manufacturing profits. Many pharmaceutical organizations are laying emphasis on developing unavailable drugs, in order to cater to growing demand. For instance, in June 2021, Bristol Mayer Squibb received the U.S. Food and Drug Administration (FDA) approval for Zeposia indicated for the treatment of inflammatory bowel disease (IBD).

2.  High demand for hormonal therapy can provide major business opportunities in the market

The demand for hormonal replacement therapy is gaining significant traction. Hormone replacement therapy is typically used in the treatment of symptoms associated with hormonal imbalance and menopause. Furthermore, growing demand for hormonal therapy can provide major business opportunities.

Buy This Premium Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/3199

Market Trends

1.  North America Trends

North America is expected to witness significant growth in the global compound pharmacies market during the forecast period. This is owing to increasing demand for drugs prone to medicinal drought, innovative therapeutic areas, and personalized dosages. Furthermore, the presence of favorable government policies and increasing acceptance of compounding pharmacies is expected to boost the regional market growth over the forecast.

2.  Asia Pacific

Asia Pacific is expected to register a robust growth rate, owing to improving healthcare sector and rising incidence of chronic diseases such as cancer, diabetes, CVD across the region. Moreover, growing geriatric population is expected to boost the regional market growth in the near future.

Competitive Section

Major companies involved in the global compounding pharmacies market are Athenex Pharma Solutions (Athenex Inc.), B. Braun, Clinigen Group PLC, Dougherty's Pharmacy, Inc., Fagron, Fresenius Kabi, Institutional Pharmacy Solutions, Lorraine's Pharmacy, McGuff Company Inc. (McGuff Compounding Pharmacy Services), Nephron Pharmaceuticals Corporation, Pencol Compounding Pharmacy, Rx3 Compounding Pharmacy, and Triangle Compounding Pharmacies.

For instance, in August 2021, MEDISCA launched a new thyroid active pharmaceutical ingredient (API), creating a consistent supply for compounding pharmacists.

Global Compounding Pharmacies Market, By Region:

  • North America
    • By Country:
      • U.S.
      • Canada
  • Europe
    • By Country:
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country:
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East & Africa
    • By Country:
      • GCC Countries
      • Israel
      • South Africa
      • Rest of Middle East & Africa

Need Customize Report? Please Visit @ https://www.coherentmarketinsights.com/insight/request-customization/3199

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

Contact Us:

Mr. ShahSenior Client Partner - Business DevelopmentCoherent Market Insights Phone: US: +1-206-701-6702 UK: +44-020-8133-4027 Japan: +81-050-5539-1737 India: +91-848-285-0837 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com Follow Us:  LinkedInTwitter

View original content: https://www.prnewswire.com/news-releases/compounding-pharmacies-market-to-grow-us-14-116-4-mn-by-end-of-2028--says-coherent-market-insights-301418628.html

SOURCE Coherent Market Insights


AI voice cloning is an advanced artificial intelligence technology that leverages deep learning, neural networks, and natural language processing to accurately replicate a person's voice using only brief audio samples.

It analyzes unique voice characteristics such as pitch, tone, rhythm, speed, and cadence to generate synthetic speech that closely mimics the original speaker.

Recent developments have greatly simplified access to voice cloning technologies, allowing even non-experts to clone voices with as little as three seconds of audio input.

Notable AI models like Microsoft’s VALL-E demonstrate how quickly and realistically voice cloning can be achieved today[ e3eac26f-b4ab-4cad-a17b-244b8a501047_871210594].

The technology has evolved sharply over the past few years, with key breakthroughs involving unstructured training on thousands of hours of voice data, allowing AI not only to reproduce what is said but also how it is said.

Open-source systems like Tortoise laid the foundation for commercial platforms such as Elevenlabs and NeuralSpace’s VoiceAI, which offers high-accuracy, culturally attuned synthetic voices, including local dialects in Arabic, Hindi, and English, facilitating authentic, engaging user experiences across industries.

The typical process involves collecting quality audio samples, training AI models to learn voice features, and generating speech on demand.

Applications of voice cloning span entertainment (voiceovers, video games, films), accessibility (aids for individuals with speech impairments), virtual assistants, education (including language learning tools), business, marketing, and customer service automation.

In education, voice cloning holds promise for creating authentic listening comprehension materials customized to specific proficiency levels, which could address your need for realistic yet accessible foreign language audio content.

However, the ethical use of this technology demands careful consideration of voice consent and authenticity.

AI voice cloning is an advanced artificial intelligence technology that leverages deep learning, neural networks, and natural language processing to accurately replicate a person's voice using only brief audio samples.

Title:

Content: Opinions and Articles
What is deepfake technology and how does it work?
What is deepfake technology and what is its mechanism of action and the limits of its potential that can be used to fake videos, images and sounds?
# Alert your personal opinion as a specialist in the field in the last post:
Deepfake is a very dangerous artificial intelligence technique that is used in the manufacture and counterfeiting of videos, images and sounds, which can show people saying or doing things they never said or did in fact and can reach high accuracy in it with the large size of data used in the training of the quasms that the technology works on.
Let ’ s start with Voice Deepfake, also known as Voice Cloning, is an artificial intelligence technique designed to create quasmids capable of imitating the voice of a real person.
In order to do this, it must be trained on the recordings of the target person and after the completion of the training phase, the algorithm is able to produce a synthetic voice similar to the voice of the target person.
To do this, specialists use natural language processing techniques such as NLP, a machine learning technique that enables computers to interpret, process, and understand human language.
These techniques are used to identify the distinctive voice features of the voice of the target person and there are a large number of voice features that are analyzed, including the feature of pitch and low voice so that there are people characterized by high voice and others by low voice, and is also analyzed speed feature in the nature of the speech of the target person, and also of these features Cadence, which is the way the voice of the target.
Of course, to reach high accuracy, there must be huge data to train Khasmia many recordings of the target person and the easiest way to reach quick results to falsify the voice of a person is to use one of the existing Khasmia online open source and the transfer learning technology on it and train the algorithm on a simple recording can Khasmia trained high precision easily identify the voice features and imitate.
But the problem is that most of the existing algorithms yes are high precision but they have been trained on either recordings in English or classical Arabic and algorithms trained on ZD data for those who enter a section in Sudanese bicycles get what is known as data drifting and this leads me a sharp decline in the accuracy of the results of the algorithm so you will find the product section very clear that it is fake.
Good and solution?
In the case of trying to fake the voice of a person in a Sudanese dialect using the technology of transfer learning will not benefit and will not come satisfactory results so you must train Khasmia from scratch on data using too many clips for the target person and is a very cumbersome process so you find there is a Russian company that offers this service to produce clips in English to fake videos and voice me anyone but at a cost of $20,000 per minute English can cost you $100,000.
The conclusion of the personal opinion that the audio in the video is real, but the video may be an old video was installed audio and adjust the synchronization and movement of the lips using the Deepfake technology in the video I noticed in the movement of the lips of the speaker some errors in the synchronization between what is said and the movement of the lips.
with my regards,
M.M. Mohammed A.M.
Valid
Researcher and Engineer Automated Robotics and Expert Artificial Intelligence Systems
London, United Kingdom
# Cher _ in _ the _ good
A dose of awareness
# شير _ على _ معر _ مع

What is necessary for voice cloning to work?

It analyzes unique voice characteristics such as pitch, tone, rhythm, speed, and cadence to generate synthetic speech that closely mimics the original speaker.

Title:

Content: Expressionkaspersky.com
What are the mysteries of deep sonic falsification?
The spread of artificial intelligence and easy access to tools capable of altering the truth have led to the emergence of one of the most shocking and disturbing digital manipulation techniques, “deepfake. ”
Deep fakes make it possible to create fake videos, photos and sounds that show individuals saying or doing things they never said or did, and although the most popular version until recently was video, deep fakes are gaining importance day by day.
A historical overview
The first major program to bring the potential of deep voice counterfeiting to the general public was Adobe Voco in 2016, which used artificial intelligence to mimic a person ’ s voice from a short recording.
emoticalipwatchdog.com
The software was scrapped after it was found that it could be used to create false, misleading and dangerous sounds, and since then, advances in neural network technology have enabled increasingly realistic and convincing audio falsifications.
At present, we can find many applications and tools online that use this technology to create fake sounds, where Microsoft has launched an artificial intelligence model called VALL-E that can imitate the human voice with a recording of only three seconds.
Deep sonic falsification
Deep voice falsification aims to create an audio model capable of replicating the actual speaker ’ s voice, but the model must be trained through the speaker ’ s audio recordings, in order to be ready to generate an artificial sound similar to that of the original person.
expressiontelegraph.co.uk
Deep learning and natural language processing techniques are used to analyze the unique patterns and characteristics of sound, some of which include pitch, speed, rhythm and tone, and artificial intelligence uses recordings to deliver an original sound, creating a new audio recording that mimics the speaker ’ s voice to a full degree.
How to Create Deep Audio Counterfeiting
Fake deep voice is created using AI-powered text to speech technology, and this can be done with just a few minutes of recorded speech to train an AI speech model, which can read any text with the target voice.
expressionveritonevoice.com
The original recorded sound must be of sufficient quality to sample the unique characteristics of the speaker ’ s voice, after which AI algorithms analyze the patterns and characteristics of the original sound and learn to mimic them.
This can be done with male and female voices and adaptation to the identity of the speaker, the result is a fake voice recording that mimics the voice of the original person, and in addition to generating speech, these instruments can simulate sounds such as breathing and mouth movements.
Initiatives to combat voice counterfeiting
There are initiatives aimed at combating this increasingly prevalent voice counterfeiting, and some technologies can detect these counterfeit products, such as voice biometrics, an authentication method that uses a person ’ s unique voice pattern to verify their identity.
expressionclt.nliu.ac.in
This pattern includes characteristics such as tone and pitch of the voice, speech speed, and pronunciation, and to use voice biometrics, a person's voice must be captured, after which, its unique characteristics are analyzed as well as the length of the words.
Spectroscopy can also be used, consisting of analyzing acoustic signals to detect unique sound patterns that are difficult to replicate in deep fakes.
There are also tools that can detect the digital traces present in deep voice fakes, because the latter fails to accurately simulate all the variables of the actual voice recording, and therefore, deep fakes may contain breaks in sound or background noise that differ from those expected in the original sound.
Most Read
No stories found.
Erm News
www.eremnews.com

Deepdub, a film dubbing company, uses an AI to process voice and translate into a different language and promises to preserve what?

Recent developments have greatly simplified access to voice cloning technologies, allowing even non-experts to clone voices with as little as three seconds of audio input.

Title:

Content: The scary side of artificial intelligence

The pros of AI outweigh the Cons or threats in our day-to-day lives, and there’s no magic pill to protect us from the scary threats of AI.

  • Exclusive

It's a free Content, simply login/signup to unlock

Get in-depth Industry Insights and Analysis through our “Exclusive” content, presented to you by our esteemed panel of writers, for free

By continuing, you agree to the Terms & Conditions and acknowledge our Privacy Policy. This same account can be used across all Economic Times B2B portals.

  • Updated On Oct 3, 2023 at 03:02 PM IST

Artificial intelligence (AI), as we all know, is the simulation of human intelligence leveraging computer systems and machines. AI programs can continuously learn and evolve with experience. In technical terms, AI systems render the output by churning and analyzing the data for correlations and patterns and help make future predictions using these patterns.

Advt
Today AI is being used extensively in all facets of our lives starting from lifestyle, e-commerce, home appliances, automobiles, navigation, transport, healthcare, agriculture, education, financial planning, chatbots, marketing, cyber security, virtual assistant, industrial automation and many more.

Clearly, we have and are leveraging the strengths of AI to the fullest to automate the routine tasks and make it auto-learn over a period. There’s no doubt that AI has revolutionized the lives of all – organizations, consumers etc. But as they say, “Everything comes at a price”. This analogy is quite true for AI as well, there have been a lot of threats that have emerged using AI and are being utilized by the Cyber criminals to dupe the ignorant users, cause mental stress and extort money.

continued below

Executive Workshop

I’m not going to delve into all of threats but would like to elucidate some of the real ones that have come to the surface recently:

Voice cloning or mimicry

As the name suggests, it uses machine learning algorithms to simulate anyone’s voice. It requires certain voice data to analyze and learn the specific patterns of any individual. There are certain advantages of cloning a voice that can be used in voice assistants, chatbots, navigation systems and other areas. Voice cloning has existed for a while but was restricted to experts who possess the technical knowledge to be able to use the same. But now AI Voice cloning tools are available on the open Internet that anyone can leverage with literally no technical knowledge or cost to clone anyone’s voice. All you need to do is just Google and it will pop up and get a bunch of both free and paid AI Voice cloning tools.

Advt
In fact, recently one of the global leaders in online protection published a report stating how AI is fueling a rise in online voice scams, with just three seconds of audio required to clone a person’s voice. This is extremely creepy. Just imagine, if a Cyber-criminal clones your voice and tricks your near ones by making them believe that they are talking to you, and request for money due to any distress reasons. In fact, these are not assumptions but real-life incidents that are happening across the world every minute.

Deepfakes AI

Deepfakes AI are being used to impersonate an individual by manipulating videos, images, audios, and other content available on the social media platforms using deep learning techniques. It mainly transforms existing content from one person to another. This is another area that has been exploited by the Cyber criminals in the recent past, and there are a few deepfake cases that have made waves on the Internet. One of the most famous ones being Deepfake created by a VFX artist of one of Hollywood’s most famous male actors. This piece was so well made by rendering thousands of pictures using artificial versions of the actor. There are similar Deepfakes incidents involving other global celebrities and leaders. The damage and misuse of the deepfakes videos could be extremely dangerous for the human society and can be used by terrorists to incite riots and create nuisance.

Creating virtual people

This is another area where AI is being used to create people that do not exist. There are a lot of websites that allow you to generate a random image by just specifying the age group, gender & ethnicity, and you can continue to refresh these images at the click of a button. Be mindful of the fact that these images pertain to people that do not exist in this world. On the similar lines, there’s an emerging trend of AI news anchors that possess a human-like appearance and are fed data that they can read using text-to-speech technology. Recently, there's been a surge of AI-Driven robotic new anchors in multiple language channels. While the main objective of this initiative is to provide royalty free or cost-effective human images for branding and other purposes. However, the overuse of these technologies causes Fear of missing out (FOMO), Feeling of inadequacy, dissatisfaction, and isolation may potentially lead to psychological and emotional vulnerabilities.

One of the Hollywood movies, ‘HER’ portrayed an introverted and lonely writer (Joaquin Phoenix) who purchases an AI virtual assistant personified through a female voice to assist him in his writing job. However, when he finds out about its ability to learn and adapt, he falls in love with it. The film delves into emotional vulnerability and the impact of AI on human relationships.

Needless to say, that the pros of AI outweigh the Cons or threats in our day-to-day lives, and there’s no magic pill to protect us from the scary threats of AI. However, there are certain preventive tips that one can follow to mitigate any such risks. Do spread awareness with your family and friends:

  • Set some code words with family, and friends to verify the identity during emergency circumstances
  • Optimize social media presence by limiting your connections with only known contacts and avoid connecting with any unknown ones
  • Avoid saying ‘Yes’ as a greeting while receiving unknown calls as it can be used to authorize credit card charges or other purposes
  • Continuously update privacy settings on social media to allow viewing by friends and family only
  • Avoid clicking on any suspicious links or calls received without proper due diligence
  • Do not share your passwords and other sensitive information with anyone
  • Verify the credentials of any online information before circulating it through various mediums
  • Avoid public Wi-Fi connections offered at coffee shops or airports, which requires to enter password
  • Closely monitor the time spent by younger generation on social media and online gaming
  • Finally, in case of any suspicion, double check and report it to the host site or concerned authorities
The author is the CIO of MOVIN

Disclaimer: The views expressed are solely of the author and ETCIO does not necessarily subscribe to it. ETCIO shall not be responsible for any damage caused to any person/organization directly or indirectly.

  • Published On Oct 3, 2023 at 03:02 PM IST

Most Read in Artificial Intelligence

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETCIO App

  • Get Realtime updates
  • Save your favourite articles

What is necessary for voice cloning to work?

Notable AI models like Microsoft’s VALL-E demonstrate how quickly and realistically voice cloning can be achieved today[ e3eac26f-b4ab-4cad-a17b-244b8a501047_871210594].

The technology has evolved sharply over the past few years, with key breakthroughs involving unstructured training on thousands of hours of voice data, allowing AI not only to reproduce what is said but also how it is said.

Title:

Content: OpenAI's Johansson gaffe pushes voice cloning into spotlight

Law enforcement warned that AI clones could be used to extort money from loved ones over the phone

By AFP

  • Follow us on

Scarlett Johansson voiced an AI character in the film "Her". — Reuters file

Published: Mon 27 May 2024, 7:51 PM

Last updated: Mon 27 May 2024, 7:52 PM

OpenAI was forced to apologise to actor Scarlett Johansson last week for using her voice -- or something very similar -- on its latest chatbot, throwing the spotlight on to voice-cloning tech.

Although OpenAI denied the voice they used was Johansson's, their case was not helped by CEO Sam Altman flagging the new model with a one-word message on social media -- "Her".

Johansson voiced an AI character in the film "Her", which Altman has previously said is his favourite film about the technology.

Right from the start, AI voice cloning has proved problematic.

Last year, British firm Elevenlabs went viral for all the wrong reasons when it released its voice-cloning software.

Internet pranksters immediately began pushing out deepfaked celebrities -- Harry Potter star Emma Watson was shown reading Hitler's Mein Kampf.

Law enforcement warned that AI clones could be used to extort money from loved ones over the phone.

The technology has developed rapidly in the past year becoming far more realistic and nuanced.

Danish entrepreneur Victor Riparbelli, CEO of British AI firm Synthesia, told AFP it was largely down to a program called Tortoise that was released two years ago.

The program's developers threw thousands of hours of voice data into their model in an unstructured way and discovered it not only learnt what to say but how to say it.

"That was a pretty big paradigm shift," Riparbelli said on the sidelines of last week's VivaTech conference in Paris.

Tortoise was an open source program and Elevenlabs was the first to go to market using it.

OpenAI uses similar systems though they do not release any details.

Much of the controversy around voice cloning has focused on concerns over people misusing the software.

But the claim against OpenAI is unusual because it is the company itself accused of playing fast and loose.

"It was very unfortunate that OpenAI did that -- really not very good," Katya Laine, CEO of TALKR.ai, told AFP at VivaTech.

"If they actually cloned her voice without her knowing then I think that's very very bad," said Riparbelli.

The two entrepreneurs are among hundreds harnessing AI voice programs for uses that they argue will make companies more efficient.

Laine's firm provides virtual voice assistants -- essentially AI customer service agents.

She said her firm's system could now resolve 25 to 30 percent of calls without any human involvement.

Synthesia specialises in video avatars, which Riparbelli said allowed any office worker to turn text or slides into a video performed by a realistic AI.

Both Riparbelli and Laine allow their clients to use their own avatars, off-the-shelf products or those supplied by the likes of OpenAI and Elevenlabs.

Riparbelli said Synthesia used actors whose likenesses and voices were licensed for two years with an option to renew after the initial period.

The problems arise if actors' voices are used without their consent.

The fiasco overshadowed a developer conference in Paris last week when OpenAI was showing off a suite of new tools.

In front of a big screen in an auditorium, Romain Huet, OpenAI's Head of Developer Experience, breezily chatted into his phone.

Seconds later, his short voice sample had been processed and could be heard commentating over a generated video -- in five languages.

The demonstration showed how quickly the field is moving, but the headlines had already been written.

The Washington Post asked in a newsletter "How dumb is OpenAI?", other commentators were suggesting wunderkind Altman was nothing more than a huckster.

Nonetheless, Riparbelli was open to OpenAI's argument that they had used another actor who just sounded liked Johansson.

"If it's not her but someone who sounds a lot like her... where do you draw that line," Riparbelli asked.

"If they're not allowed to use someone who sounds a lot like her, then it sets a very odd precedent."

More news from World

Deepdub, a film dubbing company, uses an AI to process voice and translate into a different language and promises to preserve what?

Open-source systems like Tortoise laid the foundation for commercial platforms such as Elevenlabs and NeuralSpace’s VoiceAI, which offers high-accuracy, culturally attuned synthetic voices, including local dialects in Arabic, Hindi, and English, facilitating authentic, engaging user experiences across industries.

Title:

Content: There were 107 press releases posted in the last 24 hours and 446,378 in the last 365 days.
VoiceAI, technology for local dialects, transforming global customer service experiences
NeuralSpace launches AI voices in local languages
NeuralSpace logo
NeuralSpace's VoiceAI platform
LONDON, UNITED KINGDOM, December 10, 2023 / EINPresswire.com / --
NeuralSpace, a leader in linguistic artificial intelligence, has launched a transformative voice technology feature within its VoiceAI platform, offering realistic artificial sounds in Arabic, Hindi and English.
The innovation, unveiled on December 11, marks a major development in sound technology, offering speech formulation with unparalleled precision, especially in local dialects such as Saudi Arabia.
Three main advantages characterize NeuralSpace ’ s offerings:
Cultural Interaction: Artificial sounds capture the essence of local dialects, fostering deep communication between users and technology in regions such as Saudi Arabia, India and the English-speaking world.
Instantaneous Interaction: VoiceAI technology provides instantaneous, natural-sounding voice feedback, which is essential for dynamic speech generation in virtual assistants and voice response systems.
Ease of integration: The technology is sophisticated but easy to use, allowing developers to effortlessly optimize their applications.
VoiceAI for NeuralSpace meets the growing demand for accurate transcription, speech analytics and authentic synthetic sounds.
These AI sounds are finely tuned to real-world interactions, providing engaging and realistic user experiences.
Felix Le Mans, CEO and co-founder of NeuralSpace, said:
“NeuralSpace was founded with a vision to make the technology globally available in any language.
Today, with the release of our natural AI sounds, we are one step closer to turning this dream into reality.
Our human-quality Saudi, Indian and English voices in AI are not just revolutionizing technological innovation; they are gateways to make dialectical interactions with technology a tangible experience for everyone. ”
About VoiceAI: This platform and application programming interface (API) allow companies to copy, translate and analyze voice data with exceptional accuracy, especially in Arabic and Hindi.
Key features include up to 91% copy accuracy for these languages, surpassing major tech brands.
The platform also ensures high-level data security through in-house deployment, NeuralSpace ’ s ISO 27001 certification and compliance with the General Data Protection Law.
NeuralSpace invites you to integrate VoiceAI into your systems, and promises to change customer experiences.
The platform can be accessed via a code-free web platform, REST APIs, and Python SDK, ensuring easy integration.
About NeuralSpace: At the forefront of linguistic artificial intelligence, NeuralSpace is committed to technologies that enhance human-machine communication.
VoiceAI embodies this vision, reflecting the diversity and richness of human languages.
For more information, demos or enquiries, visit www.neuralspace.ai or contact sales @ neuralspace.ai.
NeuralSpace ’ s latest innovation is more than just a technological advance; it ’ s a step towards a future where you not only understand technology but also speak with a voice that resonates with the cultural richness of human languages.
Melanie Swamy-Brown
NeuralSpace
melanie @ neuralspace.ai
Visit us on social media:
Twitter
LinkedIn
Youtube

The typical process involves collecting quality audio samples, training AI models to learn voice features, and generating speech on demand.

What is necessary for voice cloning to work?

Applications of voice cloning span entertainment (voiceovers, video games, films), accessibility (aids for individuals with speech impairments), virtual assistants, education (including language learning tools), business, marketing, and customer service automation.

How will educational institutions benefit from developing AI voice audio content for languages learners?

Enhance language comprehension
Enhance pronunciation abilities

In education, voice cloning holds promise for creating authentic listening comprehension materials customized to specific proficiency levels, which could address your need for realistic yet accessible foreign language audio content.

How will educational institutions benefit from developing AI voice audio content for languages learners?

Respond to different learning demands
Enhance language comprehension

However, the ethical use of this technology demands careful consideration of voice consent and authenticity.